HGHVX Mutual Fund

HGHVX Mutual Fund

NAV$51.97
See how much of HGHVX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 81 holdings · as of Jul 31, 2026
HGHVX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
12.03%		12.0%80,883$92.92MHealth CarePharmaceuticals
2
JNJ
Johnson & Johnson -Health Care · Pharmaceuticals
6.74%		18.8%203,265$52.11MHealth CarePharmaceuticals
Sector and industry · Pro
3
MRK
Merck & Company Inc
5.99%		24.8%355,648$46.31M
4
UNH
Unitedhealth Group Inc
4.73%		29.5%88,244$36.57M
5
ABBV
AbbVie Inc.
4.21%		33.7%129,664$32.54M
6
ELV
Elevance Health Inc
3.00%		36.7%61,615$23.16M
7
ISRG
Intuitive Surgical Inc.
2.87%		39.6%62,861$22.21M
8
CVS
Cvs Health Corp.
2.84%		42.4%210,042$21.93M
9—Nvaesrtex Pharmaceuticals Inc
2.64%		45.0%42,701$20.37M
10
DHR
Danaher Corp
2.57%		47.6%101,835$19.86M
11
EW
Edwards Lifesciences Corp
2.48%		50.1%222,690$19.17M
12
COR
Cencora Inc
2.46%		52.6%61,017$19.00M
13
REGN
Regeneron Pharmaceuticals, Inc.
2.02%		54.6%20,444$15.59M
14
BSX
Boston Scientific Corp.
1.93%		56.5%318,903$14.90M
15
HCA
Hca-the Healthcare Co
1.88%		58.4%36,047$14.51M
16
ABT
Abbott Laboratories
1.82%		60.2%133,195$14.08M
17
TMO
Thermo Fisherscientific Inc.
1.58%		61.8%21,279$12.22M
18
A
Agilent Technologies Inc
1.54%		63.3%85,848$11.88M
19
AMGN
Amgen Inc.
1.39%		64.7%27,841$10.72M
20
BIIB
Biogen Inc.
1.36%		66.1%51,870$10.53M
21—Stryker Corp 3.375 11/25
1.23%		67.3%29,293$9.54M
22—GSK plc
1.17%		68.5%346,649$9.01M
23
MDT
Medtronic Plc Ordinary Shares
1.12%		69.6%101,577$8.67M
24
CNC
Centene
1.10%		70.7%136,277$8.48M
25
INCY
Incyte Corp.
0.94%		71.6%61,086$7.30M
26
DXCM
Dexcom Inc.
0.91%		72.5%84,606$7.06M
27
UTHR
United Therapeutics Corp
0.87%		73.4%13,024$6.74M
28—Steris Plc_None_0
0.85%		74.3%28,649$6.54M
29
CAH
Cardinal Health Inc.
0.82%		75.1%27,409$6.30M
30—Ucb Sa
0.81%		75.9%24,310$6.24M
31—AstraZeneca PLC
0.79%		76.7%35,800$6.07M
32
ASND
Ascendis Pharma A/S
0.75%		77.4%23,901$5.83M
33
BMY
Bristol-Myers Squibb Co.
0.75%		78.2%88,181$5.76M
34
ELAN
Elanco Animal Health, Inc Cvr
0.73%		78.9%215,158$5.67M
35
CYTK
Cytokinetics Inc
0.72%		79.6%72,039$5.56M
36
MDGL
Madrigal Pharmaceuticals Inc
0.71%		80.3%11,677$5.46M
37
PTCT
Ptc Therapeutics Inc
0.70%		81.0%79,446$5.40M
38
IONS
Ionis Pharmaceuticals Inc
0.70%		81.8%104,043$5.39M
39
GALD
Galderma
0.68%		82.4%24,060$5.24M
40
ALNY
Alnylam Pharmaceuticals Inc.
0.66%		83.1%24,864$5.11M
41
RVMD
Revolution Medicines Inc
0.65%		83.7%26,888$5.04M
42
PTGX
Protagonist Therapeutics Inc
0.62%		84.4%35,155$4.80M
43
BBIO
Bridgebio Pharma Inc_None_0
0.59%		85.0%57,222$4.58M
44
HTFL
Heartflow, Inc.
0.59%		85.5%182,088$4.59M
45
RCUS
Arcus Biosciences Inc
0.58%		86.1%160,316$4.52M
46
IRON
Disc Medicine, Inc.
0.56%		86.7%55,907$4.30M
47—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
0.54%		87.2%4,871$4.16M
48—Emcompass Health Corp
0.54%		87.8%37,246$4.14M
49
CLDX
Celldex Therapeutics Inc
0.52%		88.3%104,861$3.99M
50
DNTH
Dianthus Therapeutics Inc
0.52%		88.8%37,237$3.98M
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 31 holdings of HGHVX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

HGHVX Mutual Fund All Holdings

HGHVX holdings total 85 positions. The top 10 holdings account for 47.6% of the fund, led by Eli Lilly & Co. at 12.0%, Johnson & Johnson - Common at 6.7%, Merck & Company Inc at 6.0%.

HGHVX portfolio concentration is moderate, with the top 10 representing 47.6% of total assets. The largest sector exposure is Health Care at 86.2%.

HGHVX sectors provide a detailed breakdown. HGHVX overlap shows how holdings compare to other funds in your portfolio.